Drop the ‘emergency use’ part. Pfizer’s vaccine just got FDA approval.
There are three COVID-19 vaccines on the US market: Pfizer's, Johnson & Johnson's, and Moderna's. All three have been greenlighted for emergency use. Meaning, they showed enough efficacy early on to get the provisional go-ahead. Now, after reviewing 340,000 pages of data, the FDA is patting itself on the back for the call.
Pfizer’s clinical trial followed thousands of subjects for at least six months – up from the two months needed for emergency use authorization. The FDA found that serious side effects like heart inflammation were still extremely rare. Also, that efficacy at preventing COVID-19 six months out was 91%. Worth noting: that six-month period wrapped up before the delta variant hit. Delta is believed to have taken a big hit on efficacy.
Correct. Pfizer plans to ask the FDA to give it the full approval for boosters, too – something the Biden admin wants to start rolling out for people soon. Meanwhile, Moderna is waiting for its turn to get the FDA’s full approval. J&J says it will file later this year. But heads up: the full approval for Pfizer is only for people 16 and up. Kids ages 12-15 can still get vaccinated under the FDA’s emergency use authorization.
There are about 85 million unvaccinated Americans eligible to get shots. The Biden admin is hoping the FDA’s endorsement for Pfizer will ease some of their concerns. One poll found that 31% of unvaccinated adults said that the FDA’s full approval would make them more likely to get it. The move could also open the door wider for mandates. Following the announcement, the Pentagon said it’s moving ahead with vaccine requirements for service members. It comes as NYC requires all public school staff to get at least one dose over the next month.
Never before in the history of the FDA has the agency reportedly had this much data to look at when approving a vaccine. Now, as delta wreaks havoc on the country, health officials are hoping the FDA’s stamp of approval will give a boost of confidence to those still hesitant of rolling up their sleeves.
PS: The FDA’s approval could mean your workplace will require a COVID-19 vaccine. Wondering if it’s legal? The short answer: yes.
Afghanistan. Yesterday, the Taliban warned of “consequences” if the US stayed past the end of the month. August 31 was the most recent date the Biden admin gave for when it would end its military mission. But then the Taliban took over Kabul last week, and the admin called in backup (think: more troops) to help evacuate thousands of Americans and Afghan allies. The Taliban threat came after President Biden said Sunday he’s in talks with military officials about potentially staying past the end of the month. But a Taliban spokesperson says the move would “create mistrust” and “provoke a reaction.” It all comes amid...
Violence: Gunfire broke out near the airport early yesterday when an unknown person fired on Afghan security forces. NATO officials say at least 20 people have died there since the evacuation effort began last week. And violence is continuing throughout the country.
Pressure: Today, G7 world leaders are meeting over Zoom to talk about the situation in Afghanistan. UK PM Boris Johnson is expected to ask Biden to keep US boots on the ground past the end of the month. And discuss possible sanctions against the militant group.
The Tokyo Paralympics. The sporting event for athletes with disabilities kicks off today. Over 3,500 athletes will compete across 540 events – including badminton and taekwondo for the first time ever. At least 28 LGBTQ+ Paralympians will be vying for medals – a record. Medalists Chuck Aoki and Melissa Stockwell will be the US’s flag bearers during the opening ceremony at 6:55am ET. Plus, get to know these athletes. The games run until Sep 5. Stay tuned here.
Not without controversy: The Paralympics come amid surging COVID-19 cases in Japan. Coronavirus restrictions have forced at least one athlete to withdraw from the games because she couldn’t bring a personal care assistant.
Kathy Hochul. Today is her first official day as the first female governor of New York. And she’s bringing women into leadership positions with her. Meet Karen Persichilli Keogh and Elizabeth Fine.
Starbucks also knows to give the people what they want.
Beyoncé's making history with the Tiffany diamond.
Skimm’d by Rashaan Ayesh, Maria del Carmen Corpus, Mariza Smajlaj, and Julie Shain
Sign up for the Daily Skimm email newsletter.
Delivered to your inbox every morning and prepares you for your day in minutes.
More than half of the US population is now fully vaxxed. But the virus is still a problem. Here's why.
COVID-19 vaccines first debuted in the US in December. And now, some are wondering how long the benefits of the vaccine will last and whether the inoculated will need a booster shot. Here’s what we know.
Got COVID questions? We did, too. "Skimm This" talked to US Surgeon General Dr. Vivek Murthy about what to call this big spike in cases, how bad things might get before they get better, and whether employers should be mandating employees get vaccinated.